Human medicines European public assessment report (EPAR): Hepcludex, bulevirtide, Date of authorisation: 31/07/2020, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Tibsovo, ivosidenib, Date of authorisation: 04/05/2023, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Qaialdo, spironolactone, Date of authorisation: 26/05/2023, Revision: 4, Status: Authorised

List of medicines under additional monitoring

List of medicinal products under additional monitoring

List of medicinal products under additional monitoring

Human medicines European public assessment report (EPAR): Verzenios, abemaciclib, Date of authorisation: 26/09/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): CellCept, mycophenolate mofetil, Date of authorisation: 14/02/1996, Revision: 41, Status: Authorised

Human medicines European public assessment report (EPAR): Gotenfia, golimumab, Date of authorisation: 10/02/2026, Status: Authorised

Cancer Medicines Forum: December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 2 December 2025, 16:00 (CET) to 2 December 2025, 17:00 (CET)